AllianceBernstein
ASPX

AllianceBernstein’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

AllianceBernstein’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,400
Closed -$1.44M – 3534
2015
Q1 		$1.44M Buy
14,400
+12,200
+555% +$813K ﹤0.01% 1969
2014
Q4 		$115K Sell
2,200
-1,000
-31% -$29.4K ﹤0.01% 2959
2014
Q3 		$82K Buy
3,200
+200
+7% +$4.25K ﹤0.01% 3004
2014
Q2 		$67K Buy
+3,000
New +$65.6K ﹤0.01% 3073

AllianceBernstein's ASPX Position: Q2 2015 in Review

AllianceBernstein sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 14,400 shares — an estimated $1.44M sold.

AllianceBernstein first reported a position in ASPX in Q2 2014 and held it in 4 quarters. The position peaked at $1.44M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • AllianceBernstein reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 14,400 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.44M.
  • AllianceBernstein first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • AllianceBernstein's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.44M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.